BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML
Titel:
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML
Auteur:
Press, Richard D. Love, Zac Tronnes, Ashlie A. Yang, Rui Tran, Thuan Mongoue-Tchokote, Solange Mori, Motomi Mauro, Michael J. Deininger, Michael W. Druker, Brian J.